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Background
In Thailand where virtually all pregnant women are
infected with HCMV, about 2% of infants are congenitally
infected with HCMV [1]. However, the transmission rate
among infants born to HIV-1 infected mothers is not well
known. Our objectives were to evaluate HCMV transmis-
sion rates in infants born to HIV-1 infected mothers, and
to identify maternal and newborn risk factors associated
with infant HCMV infection.
Materials and methods
Ninety-seven HIV-1 transmitting mothers were matched
on maternal plasma HIV-1 RNA before zidovudine proph-
ylaxis initiation with 194 non-transmitting mothers
enrolled in PHPT-1 [2], an HIV prevention trial in Thai-
land. Infant HCMV infection was assessed by anti-HCMV
IgM and/or HCMV DNA within 6 months of age and by
IgG serology at 18 months. Congenital HCMV infection
was defined as the presence of HCMV IgM and/or a posi-
tive DNA PCR within 10 days of life. Univariate odds ratio
(95% confidence intervals) were calculated for potential
risk factors among maternal (age, HIV and immunologi-
cal stage, pregnancy history, pregnancy complications,
induction of labor, mode of delivery, past/present sexual
transmitted diseases, CD4/CD8 T-lymphocyte counts)
and infant characteristics (HIV status, sex, prematurity
and birth weight). Adjusted odds ratios were calculated
using logistic regression with stepwise selection of varia-
bles with less than 0.20 p value association.
Results
The prevalence of congenital HCMV infection was 16%
(10/62) in HIV-1 infected infants and 5% (5/105) in
uninfected infants, p=0.013. The prevalence of HCMV
infection by 18 months of age was 83% (62/75) in HIV-1
infected infants and 62% (112/182) in uninfected infants,
p=0.001. Upon univariate analysis, among the maternal
factors, only vaginal delivery was associated with HCMV
infection in infants (OR: 2.5; 95%CI: 1.3-4.7). Among
infants' factors, HIV infection (OR: 3.3; 95%CI: 1.7-7.0)
and prematurity (OR: 3.5; 95%CI: 1.0-18.8) were associ-
ated with HCMV. Upon multivariate analysis only vaginal
delivery (OR: 2.5; 95%CI: 1.3-4.5) and infant HIV infec-
tion (OR: 3.3; 95%CI: 1.7-6.4) remained independently
associated with HCMV infection in infants.
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Infant HIV infection and vaginal delivery are the main risk
factors for HCMV infection in children born to HIV-1
infected mothers. The clinical consequences of congenital
and postnatal HCMV infection on HIV disease progres-
sion need to be assessed.
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